The role of CD147 expression in prostate cancer: a systematic review and meta-analysis

Yun Ye,1,2,* Su-Liang Li,2,* Yao Wang,2 Yang Yao,2 Juan Wang,1 Yue-Yun Ma,1 Xiao-Ke Hao1 1Department of Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, 2Department of Clinical Laboratory, The First Affiliated Hospital of Xi’an Medical University, Xi’an,...

Full description

Bibliographic Details
Main Authors: Ye Y, Li SL, Wang Y, Yao Y, Wang J, Ma YY, Hao XK
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/the-role-of-cd147-expression-in-prostate-cancer-a-systematic-review-an-peer-reviewed-article-DDDT
_version_ 1819206721285914624
author Ye Y
Li SL
Wang Y
Yao Y
Wang J
Ma YY
Hao XK
author_facet Ye Y
Li SL
Wang Y
Yao Y
Wang J
Ma YY
Hao XK
author_sort Ye Y
collection DOAJ
description Yun Ye,1,2,* Su-Liang Li,2,* Yao Wang,2 Yang Yao,2 Juan Wang,1 Yue-Yun Ma,1 Xiao-Ke Hao1 1Department of Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, 2Department of Clinical Laboratory, The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi, People’s Republic of China *These authors contributed equally to this work Background: There are a number of studies which show that expression of CD147 is increased significantly in prostate cancer (PCa). However, conflicting conclusions have also been reported by other researchers lately. In order to arrive at a clear conclusion, a meta-analysis of eligible studies was conducted.Materials and methods: We searched PubMed, MEDLINE, Cochrane Library, and the China National Knowledge Infrastructure databases to identify all the published case–control studies on the relationship between the expression of CD147 and PCa until February 2016. In the end, a total of 930 patients in eight studies were included in the meta-analysis.Results: CD147 expression in the PCa patients increased significantly (odds ratio [OR], 4.65; 95% confidence interval [CI], 3.52–6.14; Z=10.79; P<0.05), but there was obvious heterogeneity between studies (I2=92.9%, P<0.05). Subgroup analysis showed that positive expression of CD147 was associated with PCa among the Asian population (OR, 21.01; 95% CI, 12.88–34.28; Z=12.19; P<0.05). Furthermore, it was significantly related to TNM stage (OR, 0.24; 95% CI, 0.17–0.35; Z=7.74; P<0.05), Gleason score (OR, 0.41; 95% CI, 0.31–0.56; Z=5.62; P<0.05), differentiation grade (OR, 0.27; 95% CI, 0.13–0.56; Z=3.47; P<0.05), and pretreatment serum prostate-specific antigen level (OR, 0.07; 95% CI, 0.03–0.16; Z=6.47; P<0.05).Conclusion: Positive expression of CD147 was related to PCa, significant heterogeneity was not found between Asian studies, and the result became more significant. The positive expression of CD147 was significantly related to the clinicopathological characteristics of PCa. This suggests that CD147 plays an essential role in poor prognosis and recurrence prediction. Keywords: CD147, prostate cancer, meta-analysis
first_indexed 2024-12-23T05:12:06Z
format Article
id doaj.art-ed236e339aa642ea95aefa6e9df37247
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-23T05:12:06Z
publishDate 2016-08-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-ed236e339aa642ea95aefa6e9df372472022-12-21T17:58:57ZengDove Medical PressDrug Design, Development and Therapy1177-88812016-08-012016Issue 12435244228178The role of CD147 expression in prostate cancer: a systematic review and meta-analysisYe YLi SLWang YYao YWang JMa YYHao XKYun Ye,1,2,* Su-Liang Li,2,* Yao Wang,2 Yang Yao,2 Juan Wang,1 Yue-Yun Ma,1 Xiao-Ke Hao1 1Department of Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, 2Department of Clinical Laboratory, The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi, People’s Republic of China *These authors contributed equally to this work Background: There are a number of studies which show that expression of CD147 is increased significantly in prostate cancer (PCa). However, conflicting conclusions have also been reported by other researchers lately. In order to arrive at a clear conclusion, a meta-analysis of eligible studies was conducted.Materials and methods: We searched PubMed, MEDLINE, Cochrane Library, and the China National Knowledge Infrastructure databases to identify all the published case–control studies on the relationship between the expression of CD147 and PCa until February 2016. In the end, a total of 930 patients in eight studies were included in the meta-analysis.Results: CD147 expression in the PCa patients increased significantly (odds ratio [OR], 4.65; 95% confidence interval [CI], 3.52–6.14; Z=10.79; P<0.05), but there was obvious heterogeneity between studies (I2=92.9%, P<0.05). Subgroup analysis showed that positive expression of CD147 was associated with PCa among the Asian population (OR, 21.01; 95% CI, 12.88–34.28; Z=12.19; P<0.05). Furthermore, it was significantly related to TNM stage (OR, 0.24; 95% CI, 0.17–0.35; Z=7.74; P<0.05), Gleason score (OR, 0.41; 95% CI, 0.31–0.56; Z=5.62; P<0.05), differentiation grade (OR, 0.27; 95% CI, 0.13–0.56; Z=3.47; P<0.05), and pretreatment serum prostate-specific antigen level (OR, 0.07; 95% CI, 0.03–0.16; Z=6.47; P<0.05).Conclusion: Positive expression of CD147 was related to PCa, significant heterogeneity was not found between Asian studies, and the result became more significant. The positive expression of CD147 was significantly related to the clinicopathological characteristics of PCa. This suggests that CD147 plays an essential role in poor prognosis and recurrence prediction. Keywords: CD147, prostate cancer, meta-analysishttps://www.dovepress.com/the-role-of-cd147-expression-in-prostate-cancer-a-systematic-review-an-peer-reviewed-article-DDDTCD147prostate cancermeta-analysis
spellingShingle Ye Y
Li SL
Wang Y
Yao Y
Wang J
Ma YY
Hao XK
The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
Drug Design, Development and Therapy
CD147
prostate cancer
meta-analysis
title The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
title_full The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
title_fullStr The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
title_full_unstemmed The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
title_short The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
title_sort role of cd147 expression in prostate cancer a systematic review and meta analysis
topic CD147
prostate cancer
meta-analysis
url https://www.dovepress.com/the-role-of-cd147-expression-in-prostate-cancer-a-systematic-review-an-peer-reviewed-article-DDDT
work_keys_str_mv AT yey theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT lisl theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT wangy theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT yaoy theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT wangj theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT mayy theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT haoxk theroleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT yey roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT lisl roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT wangy roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT yaoy roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT wangj roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT mayy roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis
AT haoxk roleofcd147expressioninprostatecancerasystematicreviewandmetaanalysis